Iterum Therapeutics to Present at the 26th Annual HC Wainwright Global Investment Conference

DUBLIN, Ireland and CHICAGO, Sept. 6, 2024 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage pharmaceutical company focused on the development of next-generation oral antibiotics for the treatment of infections caused by multi-drug resistant pathogens in community settings, today announced that Corey Fishman, Chief Executive Officer of Iterum, will present and lead investor meetings at the 26th Annual HC Wainwright Global Investment Conference, to be held September 9-11, 2024 at the Lotte New York Palace Hotel.

Access to the HC Wainwright conference is open to qualified investors. Iterum will be presenting at 8:30 a.m. ET on September 10, 2024. Management will also be available for one-on-one interviews on-site on September 10, 2024.